首页 > 产品 > Novel inhibitors
产品编号 产品名称 CAS No.
DC3111 Canagliflozin

Canagliflozin is a highly potent and selective SGLT2 inhibitor for CHO-hSGLT2, CHO-rSGLT2 and CHO-mSGLT2 with IC50 of 4.4 nM, 3.7 nM and 2 nM, respectively.

842133-18-0
DC3112 AS-252424

AS-252424 is a novel, potent and selective inhibitor of PI3Kγ with IC50 of 33 nM.

900515-16-4
DC3123 XL388

XL388 is a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR).

1251156-08-7
DC3133 NVP-BGT226 (BGT226)

NVP-BGT226 is a novel dual PI3K/mTOR inhibitor with IC50 of 1 nM.

1245537-68-1
DC3140 Dasatinib monohydrate

Dasatinib is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases.

863127-77-9
DC3146 Sunitinib malate

Sunitinib Malate (Sutent, SU11248) is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.

341031-54-7
DC3150 Atazanavir

Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM.

198904-31-3
DC3154 Fingolimod HCl(FTY-720)

FTY720 (Fingolimod, Gilenya) is a S1P antagonist with IC50 of 0.033 nM.

162359-56-0
DC3170 Cediranib

Cediranib (AZD2171) is a highly potent VEGFR2 inhibitor with IC50 of 0.5 nM, also inhibits Flt1/4 with IC50 of 5 nM/≤3 nM.

288383-20-0
DC4102 SB269970

SB269970 is a potent and selective 5-HT7 receptor antagonist.

201038-74-6
DC4108 Sitaxentan sodium

Sitaxentan sodium (TBC-11251) is a selective endothelin receptor-A antagonist with IC50 and Ki of 1.4 nM and 0.43 nM, respectively.

210421-74-2
DC4173 VX-745

VX-745 is a potent and selective inhibitor of p38α MAPK and p38β MAPK with IC50 of 10 nM and 220 nM, respectively.

209410-46-8
DC4174 NVP-AEW541

NVP-AEW541 is a potent inhibitor of IGF-1R with IC50 of 86 nM.

475489-16-8
DC4175 BMS-911543

BMS-911543 is a potent and selective inhibitor of JAK2 with IC50 of 1.1 nM, approximately 350-, 75- and 65-fold selective to JAK1, JAK3 and TYK2, respectively.

1271022-90-2
DC4178 NVP-HSP990 (HSP990)

HSP990 is an orally bioavailable inhibitor of human heat-shock protein 90 (Hsp90) with potential antineoplastic activity.

934343-74-5
DC4182 Temozolomide

Methazolastone (Temozolomide, Temodar, Temodal) is a DNA damage inducer.

85622-93-1
DC4187 Docetaxel

Docetaxel, an analog of taxol, is an inhibitor of depolymerisation of microtubules through binding to stabilized microtubules.

114977-28-5
DC4196 Bleomycin Sulfate

Bleomycin sulfate (Blenoxane) is a glycopeptide antibiotic and an anticancer agent for squamous cell carcinomas (SCC) with IC50 of 4 nM in UT-SCC-19A cells.

9041-93-4
DC4197 Actinomycin D

Dactinomycin (also known generically as Actinomycin D ) is the most significant member of actinomycines, which are a class of polypeptide antibiotics isolated from soil bacteria of the genus Streptomyces.

50-76-0
DC4201 Fosaprepitant dimeglumine

Fosaprepitant (MK-0517, L-758,298) is a water-soluble phosphoryl prodrug for Aprepitant which is a NK1 antagonist.

265121-04-8
DC4232 Vismodegib (GDC-0449)

Vismodegib (formerly GDC-0449) is a hedgehog antagonist, is also an orally bioavailable small molecule with potential antineoplastic activity.

879085-55-9
DC5005 tw-37

TW-37 is a novel nonpeptide inhibitor to recombinant Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.29 μM, 1.11 μM and 0.26 μM, respectively.

877877-35-5
第 11 页 / 共 19 页第一页上一页下一页最末页转到